ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer
Harvard University · University of Milan · +37 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
294
total citations
- FWCI
- 63.65
- Percentile
- 100%
- References
- 73
Citations per year
Authors
32Topics & keywords
Topics
Keywords
- Medicine
- Breast cancer
- Cancer
- Oncology
- Medical physics
- Intensive care medicine
- Family medicine
- Internal medicine
No related works found for this paper.
Funding
- BCBreast Cancer Research Foundation
- ELEli Lilly and Company
- PPfizer
- AAstraZeneca
- RRoche
- SSanofi
- GSGilead Sciences
- DMDr. Miriam and Sheldon G. Adelson Medical Research Foundation
- APAriad Pharmaceuticals
- CCelgene
- QMQueen Mary University of London
- BBaxalta
- LLLes Laboratories Pierre Fabre
- RHRadius Health
- MTMersana Therapeutics
- VVeracyte
- SSeagen
- BHBayer HealthCare
- EEisai
- APAstellas Pharma
- ESEuropean Society for Medical Oncology
- SServier
- GGenentech
- SSamsung
- FMFoundation Medicine
- DSDaiichi Sankyo Europe